Biliary excretion of rufloxacin in humans.
Rufloxacin is a new once-daily antibacterial fluoroquinolone with a long half-life. The aim of the present study was to evaluate the plasma and biliary kinetics and biliary and urinary excretion of rufloxacin in patients with extrahepatic cholestasis. Twelve patients with total external percutaneous...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1993
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192734/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8109915/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.12.2545 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|